MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Chorea following SARS-CoV-2 infection and vaccination: a systematic review

R. Bilavu, M. Simu, E. Rosca (Timișoara, Romania)

Meeting: 2023 International Congress

Abstract Number: 745

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features, Chorea (also see specific diagnoses, Huntingtons disease, etc): Etiology and Pathogenesis, Postinfectious disorders

Category: Choreas (Non-Huntington's Disease)

Objective: We aimed to investigate and compare data on chorea following SARS-CoV-2 infection and vaccination to provide an extensive perspective on this pathology and to reveal what other, more specific, research questions can be further addressed. In addition, we aimed to highlight research gaps requiring further attention.

Background: Chorea has multiple underlying causes, like genetic, immune-mediated, infectious, vascular, or metabolic conditions. Recently, chorea was reported following SARS-COV-2 infection or vaccination. Several systematic reviews on movement disorders report only a few cases in patients with COVID-19; none have assessed thoroughly or compared these two entities.

Method: We systematically reviewed two databases (LitCOVID and the World Health Organization database on COVID-19) up to February 2023. Individual patient data from case reports and case series were extracted and analyzed according to a previously published protocol.

Results: We found 16 articles reporting 14 cases of chorea in patients with COVID-19 and 8 cases in individuals receiving different types of SARS-CoV-2 vaccines. In the infection group, 42.9% of patients developed movement disorders concomitant with the viral illness. The onset was acute in 57.1% of cases and progressive in 21.4%. Also, 85.7% had generalized chorea. In the vaccination group, all patients developed acute chorea (100%), with 87.5% of cases presenting unilateral symptoms.

Conclusion: The clinical and paraclinical spectrum of chorea in patients with SARS-CoV-2 infection and vaccination is heterogeneous. Although they share some common features, they also present essential differences, possibly due to the underlying mechanisms. Future studies should aim for a comprehensive assessment of patients. In addition, there is a need for a standardized approach to investigation and reporting in this research area. Factors including the baseline characteristics of the patients, evolution, and treatments should be consistently assessed across studies, and a thorough differential diagnosis should be employed.

To cite this abstract in AMA style:

R. Bilavu, M. Simu, E. Rosca. Chorea following SARS-CoV-2 infection and vaccination: a systematic review [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/chorea-following-sars-cov-2-infection-and-vaccination-a-systematic-review/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/chorea-following-sars-cov-2-infection-and-vaccination-a-systematic-review/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley